13 results
Summary table of mechanism of action, side effect and contraindications of commonly used diabetic drugs. 

#pharmacology
Summary table of ... commonly used diabetic ... #pharmacology #dm2 ... #diabetes #medications ... overview #management #comparison
Stages in the Development of Diabetes Type 1

#Diabetes #Type1 #TypeI #DM1 #Stages #Development #Pathophysiology #Timeline #Diagnosis
Type 1 #Diabetes ... #Type1 #TypeI #DM1 ... #Development #Pathophysiology ... #Timeline #Diagnosis ... #Endocrinology
Insulin Analogs - Short, Intermediate and Long Acting - Onset, Peak, Duration

#Diabetes #Insulin #Analogs #Onset #Duration
, Duration #Diabetes ... Duration #Peaks #Comparison ... #Pharmacology # ... Endocrinology #Timing ... #Timeline
The principles of insulin adjustment guidance - Schematic diagram of insulin onset and time action profiles
and Duration #Diabetes ... Duration #Peaks #Comparison ... #Pharmacology # ... Endocrinology #Timing ... #Timeline
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Diabetes Medications ... Summary Table ... medications #table #comparison ... #management #endocrinology ... #dm2
Pathophysiology of Diabetic Ketoacidosis (DKA) and Hyperglycemic Hyperosmolar Syndrome (HHS)
Absolute Insulin deficit:
 - Type I DM:
Pathophysiology ... of Diabetic Ketoacidosis ... #dka #hhs #pathophysiology ... #comparison #endocrinology ... #diabetes #diabetic
Sulfonylureas - Pharmacology Summary
Mechanisms of Action: Binds to the ATP-sensitive potassium channel in pancreatic beta cells,
Sulfonylureas - Pharmacology ... Summary Mechanisms ... Sulfonylureas #Pharmacology ... #Summary #DM2 # ... diabetes #endocrinology
The graph illustrates the differences in the onset and duration of action for various types of
Detemir, Glargine #Diabetes ... Duration #Peaks #Timeline ... #Graph #Comparison ... #Pharmacology # ... Endocrinology
Metformin Pharmacology Summary
Mechanisms of Action:
 • Suppresses gluconeogenesis by the liver
 • Increases insulin-mediated glucose utilization
Metformin Pharmacology ... Summary Mechanisms ... #Metformin #Pharmacology ... #Summary #DM2 # ... diabetes #endocrinology
SGLT2 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits SGLT2 (sodium/glucose cotransporter 2) in the proximal tubule,
SGLT2 Inhibitors - Pharmacology ... Summary Mechanisms ... • Euglycemic diabetic ... #Summary #DM2 # ... diabetes #endocrinology